ATTD 2022 Improved Glycemic Control with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion (CSII) Therapy: Results From a Randomized Controlled Trial

228 views
May 18, 2022
1 Comment
Login to view comments. Click here to Login